546 related articles for article (PubMed ID: 25790630)
21. Sutureless aortic valve bioprothesis '3F/ATS Enable'--4.5 years of a single-centre experience.
Sadowski J; Kapelak B; Pfitzner R; Bartuś K
Kardiol Pol; 2009 Aug; 67(8A):956-63. PubMed ID: 19784899
[TBL] [Abstract][Full Text] [Related]
22. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis.
Martens S; Sadowski J; Eckstein FS; Bartus K; Kapelak B; Sievers HH; Schlensak C; Carrel T
Eur J Cardiothorac Surg; 2011 Sep; 40(3):749-55. PubMed ID: 21342776
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of a New-Generation Stentless Aortic Valve: A Single-Center Experience with 251 Consecutive Implants.
Stefanelli G; Pirro F; Danniballe G; Olaru A; Meli M; Weltert L
J Heart Valve Dis; 2017 Sep; 26(5):518-527. PubMed ID: 29762920
[TBL] [Abstract][Full Text] [Related]
25. Two alternative sutureless strategies for aortic valve replacement: a two-center experience.
Concistrè G; Santarpino G; Pfeiffer S; Farneti P; Miceli A; Chiaramonti F; Solinas M; Glauber M; Fischlein T
Innovations (Phila); 2013; 8(4):253-7. PubMed ID: 24145969
[TBL] [Abstract][Full Text] [Related]
26. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients.
D'Onofrio A; Auriemma S; Magagna P; Favaro A; Cannarella A; Piccin C; Bilotta M; Abbiate N; Lamascese N; Fabbri A
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):491-5. PubMed ID: 17662795
[TBL] [Abstract][Full Text] [Related]
27. Clinical experience with the ATS 3F stentless aortic bioprosthesis: five years' follow up.
Linneweber J; Heinbokel T; Christ T; Claus B; Kossagk C; Konertz W
J Heart Valve Dis; 2010 Nov; 19(6):772-7. PubMed ID: 21214103
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic performance of Trifecta: single-center experience of 400 patients.
Modi A; Budra M; Miskolczi S; Velissaris T; Kaarne M; Barlow CW; Livesey SA; Ohri SK; Tsang GM
Asian Cardiovasc Thorac Ann; 2015 Feb; 23(2):140-5. PubMed ID: 24823382
[TBL] [Abstract][Full Text] [Related]
29. Early clinical and hemodynamic evaluation of the aortic intact porcine bioprosthesis.
Mullany CJ; Schaff HV; Orszulak TA; Miller FA
J Heart Valve Dis; 1994 Nov; 3(6):641-7. PubMed ID: 8000607
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and hemodynamic results of the mosaic bioprosthesis in aortic position].
Botzenhardt F; Gansera B; Günzinger R; Kemkes BM
Z Kardiol; 2003 May; 92(5):407-14. PubMed ID: 12966833
[TBL] [Abstract][Full Text] [Related]
31. Clinical and hemodynamic performance of the 19-mm medtronic mosaic bioprosthesis.
Kirsch ME; Tzvetkov B; Vermes E; Pouzet B; Sauvat S; Loisance D
J Heart Valve Dis; 2005 May; 14(3):433-9. PubMed ID: 15974539
[TBL] [Abstract][Full Text] [Related]
32. Sutureless aortic valve implantation through an upper v-type ministernotomy: an innovative approach in high-risk patients.
Concistrè G; Miceli A; Chiaramonti F; Farneti P; Bevilacqua S; Varone E; Solinas M; Glauber M
Innovations (Phila); 2013; 8(1):23-8. PubMed ID: 23571790
[TBL] [Abstract][Full Text] [Related]
33. Sutureless Aortic Valve: Early and Mid-Term Results at a Single Center.
Shalabi A; Raanani E; Shinfeld A; Kuperstein R; Kogan A; Lipey A; Nachum E; Spiegelstein D
Isr Med Assoc J; 2016 Feb; 18(2):119-23. PubMed ID: 26979006
[TBL] [Abstract][Full Text] [Related]
34. Minimally invasive aortic valve replacement with Perceval S sutureless valve: early outcomes and one-year survival from two European centers.
Miceli A; Santarpino G; Pfeiffer S; Murzi M; Gilmanov D; Concistré G; Quaini E; Solinas M; Fischlein T; Glauber M
J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2838-43. PubMed ID: 24698558
[TBL] [Abstract][Full Text] [Related]
35. European multicentre experience with the sutureless Perceval valve: clinical and haemodynamic outcomes up to 5 years in over 700 patients.
Shrestha M; Fischlein T; Meuris B; Flameng W; Carrel T; Madonna F; Misfeld M; Folliguet T; Haverich A; Laborde F
Eur J Cardiothorac Surg; 2016 Jan; 49(1):234-41. PubMed ID: 25750010
[TBL] [Abstract][Full Text] [Related]
36. The aortic Elan stentless aortic valve: excellent hemodynamics and ease of implantation.
Flynn M; Iaccovoni A; Pathi V; Butler J; Macarthur KJ; Berg GA
Semin Thorac Cardiovasc Surg; 2001 Oct; 13(4 Suppl 1):48-54. PubMed ID: 11805949
[TBL] [Abstract][Full Text] [Related]
37. Sutureless aortic valve replacement: a Canadian multicentre study.
Mazine A; Teoh K; Bouhout I; Bhatnagar G; Pelletier M; Voisine P; Demers P; Carrier M; Bouchard D
Can J Cardiol; 2015 Jan; 31(1):63-8. PubMed ID: 25547552
[TBL] [Abstract][Full Text] [Related]
38. Aortic valve replacement in octogenarians: is biologic valve the unique solution?
de Vincentiis C; Kunkl AB; Trimarchi S; Gagliardotto P; Frigiola A; Menicanti L; Di Donato M
Ann Thorac Surg; 2008 Apr; 85(4):1296-301. PubMed ID: 18355513
[TBL] [Abstract][Full Text] [Related]
39. Initial experience with the Toronto Root bioprosthesis.
David TE; Mohr FW; Bavaria JE; Hammon JW; Smith MJ; Quinn RD; Bach DS
J Heart Valve Dis; 2004 Mar; 13(2):248-51; discussion 252-3. PubMed ID: 15086264
[TBL] [Abstract][Full Text] [Related]
40. First clinical experience and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis.
Wendt D; Thielmann M; Buck T; Jánosi RA; Bossert T; Pizanis N; Kamler M; Jakob H
Eur J Cardiothorac Surg; 2008 Apr; 33(4):542-7. PubMed ID: 18255309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
